Carmel Stock

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

Carmel Stock, Hiroe Sato, Carmen Fonseca et al. · Thorax · 2013 · 231 citations · Full text

Host–Microbial Interactions in Idiopathic Pulmonary Fibrosis

Philip L. Molyneaux, Saffron A.G. Willis‐Owen, Michael J. Cox et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 216 citations · Full text

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

Dina Visca, Letizia Mori, Vicky Tsipouri et al. · The Lancet Respiratory Medicine · 2018 · 215 citations · Full text

Quality Of Life, Advanced Lung Disease, Fibrotic Lung Disease +8

A Polymorphism in the<i>CTGF</i>Promoter Region Associated with Systemic Sclerosis

Carmen Fonseca, Gisela Lindahl, Markella Ponticos et al. · New England Journal of Medicine · 2007 · 200 citations · Full text

Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease

Gisela Lindahl, Carmel Stock, Shiwen Xu et al. · Respiratory Research · 2013 · 100 citations · Full text

Fibrosis, Inflammatory Lung Disease, Gene Program +13